BACITRACIN MD DIN 02408317
Status: Marketed
Holder: BIO AGRI MIX LP
Available to quote
Health Canada record
| Active ingredient(s) | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 18-Sep-2013 |
| Current status date | 27-Mar-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bio Agri Mix LP — licence 100068, currently licensed, last inspection rating C (2024-04-02).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BACITRACIN (BACITRACIN METHYLENE DISALICYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02512866 | BACITRACIN MD SOLUBLE | BIO AGRI MIX LP | Powder For Solution | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 440 MG | Approved |
| 02206099 | BMD 110 G | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G | Marketed |
| 01988751 | BMD 110 PREMIX 110GM/KG | A.L. LABORATORIES, INC. | Drug Premix | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G | Cancelled Post Market |
| 02328135 | BMD SOLUBLE | PHIBRO ANIMAL HEALTH CORPORATION | Powder For Solution | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 440 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 28220 | 2022-05-20 | Supplement to an Abbreviated New Drug Submission (SANDS) | Additional indications |
| 20372 | 2018-01-22 | Supplement to an Abbreviated New Drug Submission (SANDS) | REMOVAL OF GROWTH PROMOTION CLAIMS. CHANGE TO PRESCRIPTIOON STATUS. REMOVAL OF SPECIES (TURKEYS AND GROWER AND FINISHING PIGS. LABELLING UPDATES |
| 14479 | 2013-06-21 | Abbreviated New Drug Submission (ANDS) |